Denso took part in a $71m series D round for artificial intelligence technology provider Blaize while inflammatory disease drug developer Aristea closed a $63m Novo and Arena-backed round.
Funding
Blaize, a US-based developer of edge artificial intelligence technology, completed a $71m series D round yesterday co-led by Franklin Templeton and Temasek that included automotive component manufacturer Denso. Formerly known as ThinCI, the company had raised an undisclosed amount from Denso, peer Magna International and unnamed individuals in 2016, before Denso and its NSitexe subsidiary joined Temasek, carmaker Daimler, an undisclosed electronics producer, Mirai Creation Fund, GGV Capital, Wavemaker Partners and SG Innovate in a $65m series C…
